Skip to main content
. 2023 Aug 27;13:75. doi: 10.1186/s13613-023-01168-z

Fig. 1.

Fig. 1

COVIDICUS Trial: Main trial outcome across the DXM randomized groups. Overall survival according to randomization (a) and posterior density of the hazard ratio (HR) of the 60-day mortality rate in the whole trial population based on a noninformative prior (b) or using either a sceptical or an enthusiastic prior (c)